Summary
Although nanoparticles have been already applied on patients in clinical trials, generally nanotechnology in medicine is regarded rather a vision than a realistic option. Progress in this field arises particularly from the combination of molecular biology and nano(bio) technology. From the viewpoint of entrepreneurs nanotechnology is only a tool to develop new products, however nanotechnology itself is not a product. We developed a new cancer treatment platform technology termed MagForce Nanotherapy, in which nanotechnology has the potential to cause a revolution in tumor therapy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Jordan A, Wust P, Fahling H et al. Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993; 9:51–68.
Davis FG, Freels S, Grutsch J et al. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: An analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991. J Neurosurg 1998; 88:1–10.
Stupp R, Mason WP, Van Den Bent MJ et al. Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group. J Clin Oncol, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition) 2004; 22:2.
Pinkernelle J, Teichgraeber U, Neumann F et al. Imaging of single human carcinoma cells in vitro using a clinical whole body mr scanner at 3.0T. Magn Reson Med. 2005 May;53(5):1187–92.
Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987–996.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Jordan, A. (2006). Thermotherapy and Nanomedicine. In: Hyperthermia in Cancer Treatment: A Primer. Medical Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-33441-7_4
Download citation
DOI: https://doi.org/10.1007/978-0-387-33441-7_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-33440-0
Online ISBN: 978-0-387-33441-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)